Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for PTSD
NCT02336568Phase 4Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Peptides
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Oxytocin with Placebo (2 arms). Primary endpoints: Clinician-Administered PTSD Scale at 3 weeks, Social Function Self-Report Questionnaire at 3 weeks and 1 more. Status: unknown.
02
Drugs
oxytocin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02336568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336568.